# United Therapeutics clinical trials: 85 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 85 trials with United Therapeutics as lead sponsor, 6 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by United Therapeutics: 85 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/united-therapeutics

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 85
- Recruiting or not yet: 6
- Read on: November 19, 2026

## Trials

The 25 newest of 85, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 6, 2026 | NCT07923591 | Study of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic... | United Therapeutics | Phase 2 | Not yet recruiting | Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923591) |
| November 6, 2026 | NCT07923526 | An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic... | United Therapeutics | Phase 2/3 | Not yet recruiting | Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923526) |
| November 5, 2025 | NCT07224763 | Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD | United Therapeutics | Phase 1/2 | Recruiting | ESRD (End-Stage Renal Disease), Kidney Transplantation, Xenotransplantation | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07224763) |
| March 17, 2025 | NCT06878560 | Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD | United Therapeutics | Phase 1/2 | Recruiting | ESRD (End-Stage Renal Disease), Kidney Transplantation, Xenotransplantation | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06878560) |
| April 29, 2024 | NCT06388421 | DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) | United Therapeutics | Observational | Recruiting | Pulmonary Hypertension Due to Lung Diseases and Hypoxia, Pulmonary Hypertension, Interstitial Lung Disease | 900 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06388421) |
| July 13, 2023 | NCT05943535 | Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) | United Therapeutics | Phase 3 | Recruiting | Progressive Pulmonary Fibrosis, Interstitial Lung Disease | 698 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05943535) |
| March 20, 2023 | NCT05776225 | Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection | United Therapeutics | Observational | Completed | Interstitial Lung Disease, Pulmonary Hypertension | 314 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05776225) |
| February 25, 2022 | NCT05255991 | Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis | United Therapeutics | Phase 3 | Completed | Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease | 597 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05255991) |
| January 24, 2022 | NCT05203510 | A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular... | United Therapeutics | Phase 4 | Active not recruiting | Pulmonary Arterial Hypertension | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05203510) |
| September 29, 2021 | NCT05060315 | Evaluate Real-World Use of Next Generation Infusion Pumps to Administer Remodulin | United Therapeutics | Observational | Terminated | Pulmonary Arterial Hypertension | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05060315) |
| May 28, 2021 | NCT04905693 | Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease | United Therapeutics | Phase 3 | Enrolling by invitation | Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Progressive Pulmonary Fibrosis | 1,850 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04905693) |
| January 14, 2021 | NCT04708782 | Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis | United Therapeutics | Phase 3 | Completed | Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease | 598 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04708782) |
| September 10, 2019 | NCT04084678 | Study of Ralinepag on Exercise Capacity by Cardiopulmonary Exercise Testing (CPET) in WHO Group 1 PH Subjects | United Therapeutics | Phase 3 | Terminated | Pulmonary Hypertension, Pulmonary Arterial Hypertension | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04084678) |
| May 15, 2019 | NCT03950739 | Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso | United Therapeutics | Phase 1 | Completed | Pulmonary Arterial Hypertension | 51 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03950739) |
| March 25, 2019 | NCT03888365 | Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH | United Therapeutics | Observational | Completed | Pulmonary Arterial Hypertension | 43 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03888365) |
| February 28, 2019 | NCT03857841 | A Safety Study of IV Stem Cell-derived Extracellular Vesicles (UNEX-42) in Preterm Neonates at High Risk for BPD | United Therapeutics | Phase 1 | Terminated | Bronchopulmonary Dysplasia | 3 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03857841) |
| January 7, 2019 | NCT03794583 | Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD) | United Therapeutics | Phase 3 | Terminated | Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease | 41 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03794583) |
| September 25, 2018 | NCT03683186 | A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension | United Therapeutics | Phase 3 | Enrolling by invitation | PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension, Connective Tissue Diseases, Familial... | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03683186) |
| August 13, 2018 | NCT03626688 | A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients | United Therapeutics | Phase 3 | Completed | PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension, Connective Tissue Diseases, Familial... | 687 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03626688) |
| April 13, 2018 | NCT03497689 | EXPEDITE: A Study of Remodulin Induction Followed by Orenitram Optimization to Treat Pulmonary Arterial Hypertension | United Therapeutics | Phase 4 | Completed | Pulmonary Arterial Hypertension | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03497689) |
| April 12, 2018 | NCT03496623 | A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due... | United Therapeutics | Phase 3 | Terminated | Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease | 188 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03496623) |
| March 31, 2017 | NCT03098030 | Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer | United Therapeutics | Phase 2/3 | Completed | Small Cell Lung Cancer | 483 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03098030) |
| February 16, 2017 | NCT03055234 | Study to Evaluate Efficacy and Safety of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Sickle Cell Disease... | United Therapeutics | Phase 3 | Withdrawn | Pulmonary Hypertension Associated With Sickle Cell Disease | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03055234) |
| February 16, 2017 | NCT03055221 | TRUST-2: Safety and Efficacy of Intravenous Remodulin® in Patients in India With Pulmonary Arterial Hypertension (PAH) | United Therapeutics | Phase 4 | Completed | Pulmonary Arterial Hypertension | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03055221) |
| February 7, 2017 | NCT03045029 | ADAPT - A Patient Registry of the Real-world Use of Orenitram® | United Therapeutics | Observational | Active not recruiting | Pulmonary Arterial Hypertension | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03045029) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 13 |
| Phase 1/2 | 3 |
| Phase 2 | 15 |
| Phase 2/3 | 6 |
| Phase 3 | 26 |
| Phase 4 | 13 |
| Observational | 9 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 43 |
| Terminated | 19 |
| Withdrawn | 12 |
| Recruiting | 4 |
| Not yet recruiting | 2 |
| Enrolling by invitation | 2 |
| Active not recruiting | 2 |
| Unknown | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Pulmonary Arterial Hypertension | 44 |
| Hypertension, Pulmonary | 33 |
| Lung Diseases, Interstitial | 8 |
| Lung Diseases | 6 |
| Respiratory Tract Diseases | 5 |
| Pulmonary Disease, Chronic Obstructive | 5 |
| Hypertension | 5 |
| Vascular Diseases | 4 |
| Familial Primary Pulmonary Hypertension | 3 |
| Neuroblastoma | 3 |
| Idiopathic Pulmonary Fibrosis | 3 |
| Scleroderma, Systemic | 3 |
| Scleroderma, Diffuse | 3 |
| Chronic Limb-Threatening Ischemia | 2 |
| Peripheral Vascular Diseases | 2 |
| Connective Tissue Diseases | 2 |
| Cardiovascular Diseases | 2 |
| Emphysema | 2 |
| Renal Insufficiency, Chronic | 2 |
| Kidney Failure, Chronic | 2 |
| Respiratory Aspiration | 2 |
| Rare Diseases | 1 |
| Foot Ulcer | 1 |
| Pulmonary Fibrosis | 1 |
| Bronchopulmonary Dysplasia | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Engineering firms in the United States](https://specstream.ai/data/businesses/engineering-firms/united-states)
- [Home builders in the United States](https://specstream.ai/data/businesses/home-builders/united-states)
- [Logging companies in the United States](https://specstream.ai/data/businesses/logging-companies/united-states)
- [Pediatric clinics in the United States](https://specstream.ai/data/businesses/pediatric-clinics/united-states)
- [Salvadoran restaurants in the United States](https://specstream.ai/data/businesses/salvadoran-restaurants/united-states)
- [Translation companies in the United States](https://specstream.ai/data/businesses/translation-companies/united-states)
